[1]Suzuki T, Yamazaki T, Yazaki Y. The role of the natriuretic peptidesin thecardiovascular system[J].Cardiovsc Res,2001,51:489-494.
[2]Galvani M. Ferrini D, Oani F. Natriuretic peptides for risk stratifica-tion of patients with acute coronary syndromes[J].Eur J Heart Fail,2004,6(3):327-333.
[3]Hama N,Itoh H,Shirakami G,et al.Rapid wentricular induct-
ion of brain natriuretic peptide gene expressions in experimental acute myocardial infarction[J].Circulation,1995,92(6):1558-1564.
[4]黄伟光.冠心病病人N端前脑钠肽检测的临床意义[J].岭南心血管病杂志,2007,10(5):337-339.
[5]Mulvihill NT,Foley JB.Inflammation in acute coronary synd-
romes[J].Heart,2002,87(6):201-204.
[6]祝赛敏.老年人无症状心肌缺血与肌钙蛋白I的关系[J].中国现代医学杂志,2000,10(2):26.
[7]王树岩.辛伐他汀对急性心肌梗死合并心房颤动患者的疗效观察[J].中华心血管杂志,2005,33(1):88.
[8]罗助荣. 急性冠状动脉综合征患者降胆固醇治疗对内皮依赖性血管舒张功能、血小板及纤溶活性的影响[J].中华心血管病杂志,2001,29(9):542-545.
(收稿日期:2008-01-03;修回日期:2008-03-17)
[1]罗助荣,林 毅,张克己,等.福建地区汉族人群骨保护素基因rs2073617T/C多态性与急性冠脉综合征病变程度的关系[J].医学研究与战创伤救治(原医学研究生学报),2011,13(05):385.
LUO Zhu-rong,LIN Yi,ZHANG Ke-ji,et al.Correlation between osteoprotegerin gene rs2073617T/C polymorphism and severity of acute coronary syndromes in Fujian area[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2011,13(01):385.
[2]罗助荣.骨保护素系统与动脉粥样硬化的研究进展[J].医学研究与战创伤救治(原医学研究生学报),2010,12(06):523.
[3]陈丽萍,陈 岩,张 强,等.瑞舒伐他汀序贯治疗对急性冠脉综合征患者血清缺血修饰清蛋白、C反应蛋白、髓过氧化物酶的影响[J].医学研究与战创伤救治(原医学研究生学报),2015,17(03):272.[doi:10.3969/j.issn.1672-271X.2015.03.015]
CHEN Li-ping,CHEN Yan,ZHANG Qiang,et al.Rosuvastatin sequential therapy impact on IMA, CRP, MPO of patients with acute coronary syndrome[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2015,17(01):272.[doi:10.3969/j.issn.1672-271X.2015.03.015]
[4]王苏梦,吴 嘉,牛冬梅,等.急性冠脉综合征患者NT-proBNP、RDW和CRP的水平及相关性研究[J].医学研究与战创伤救治(原医学研究生学报),2015,17(04):362.[doi:10.3969/j.issn.1672-271X.2015.04.008]
WANG Su-meng,WU Jia,NIU Dong-mei,et al.Study of plasma level of NT-proBNP, CRP and RDW in acute coronary syndrome patients[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2015,17(01):362.[doi:10.3969/j.issn.1672-271X.2015.04.008]
[5]章荣华,陈丞,邵先安,等.脑钠肽水平低于诊断阈值的终末期心衰患者的影响因素分析[J].医学研究与战创伤救治(原医学研究生学报),2022,24(6):608.[doi:10.3969/j.issn.1672-271X.2022.06.010]
ZHANG Rong-hua,CHEN Cheng,SHAO Xian-an,et al.Analysis of risk factors in patients with end-stage heart failure whose brain natriuretic peptide level is below the diagnostic threshold[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2022,24(01):608.[doi:10.3969/j.issn.1672-271X.2022.06.010]